Clin Mol Allergy. 2007 Jan 25;5:1. doi: 10.1186/1476-7961-5-1.
Immune response modulation by curcumin in a latex allergy model.
Clinical and molecular allergy : CMA
Viswanath P Kurup, Christy S Barrios, Raghavan Raju, Bryon D Johnson, Michael B Levy, Jordan N Fink
Affiliations
Affiliations
- Department of Pediatrics, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI 53226, USA. [email protected]
PMID: 17254346
PMCID: PMC1796894 DOI: 10.1186/1476-7961-5-1
Abstract
BACKGROUND: There has been a worldwide increase in allergy and asthma over the last few decades, particularly in industrially developed nations. This resulted in a renewed interest to understand the pathogenesis of allergy in recent years. The progress made in the pathogenesis of allergic disease has led to the exploration of novel alternative therapies, which include herbal medicines as well. Curcumin, present in turmeric, a frequently used spice in Asia has been shown to have anti-allergic and inflammatory potential.
METHODS: We used a murine model of latex allergy to investigate the role of curcumin as an immunomodulator. BALB/c mice were exposed to latex allergens and developed latex allergy with a Th2 type of immune response. These animals were treated with curcumin and the immunological and inflammatory responses were evaluated.
RESULTS: Animals exposed to latex showed enhanced serum IgE, latex specific IgG1, IL-4, IL-5, IL-13, eosinophils and inflammation in the lungs. Intragastric treatment of latex-sensitized mice with curcumin demonstrated a diminished Th2 response with a concurrent reduction in lung inflammation. Eosinophilia in curcumin-treated mice was markedly reduced, co-stimulatory molecule expression (CD80, CD86, and OX40L) on antigen-presenting cells was decreased, and expression of MMP-9, OAT, and TSLP genes was also attenuated.
CONCLUSION: These results suggest that curcumin has potential therapeutic value for controlling allergic responses resulting from exposure to allergens.
References
- Allergy. 2001 Jan;56(1):2-12 - PubMed
- Methods Find Exp Clin Pharmacol. 1996 Jan-Feb;18(1):41-7 - PubMed
- Brain. 2005 Aug;128(Pt 8):1887-96 - PubMed
- J Exp Med. 2005 Sep 19;202(6):829-39 - PubMed
- Allergy. 2003 Apr;58(4):265-83 - PubMed
- Eur Respir J. 1998 Feb;11(2):312-6 - PubMed
- Bull World Health Organ. 2005 Jul;83(7):548-54 - PubMed
- Int Arch Allergy Appl Immunol. 1991;94(1-4):262-5 - PubMed
- J Lab Clin Med. 1997 Dec;130(6):567-75 - PubMed
- J Ethnopharmacol. 1997 Jan;55(2):127-32 - PubMed
- Parasitol Res. 2005 Apr;96(1):49-56 - PubMed
- Am J Physiol Lung Cell Mol Physiol. 2000 Sep;279(3):L592-9 - PubMed
- J Exp Med. 2003 Apr 21;197(8):1059-63 - PubMed
- J Immunol. 2001 Aug 1;167(3):1769-77 - PubMed
- J Clin Invest. 2003 Jun;111(12):1863-74 - PubMed
- J Asthma. 2004 Apr;41(2):131-9 - PubMed
- Vet Immunol Immunopathol. 2006 Feb 15;109(3-4):289-95 - PubMed
- Expert Opin Investig Drugs. 2005 Oct;14(10):1221-31 - PubMed
- Int Arch Allergy Immunol. 1999 Dec;120(4):270-9 - PubMed
- Infect Immun. 2004 Oct;72(10):6087-94 - PubMed
- J Allergy Clin Immunol. 2003 Jun;111(6):1232-8 - PubMed
- J Immunol. 1992 Jun 15;148(12):3783-8 - PubMed
- Int Arch Allergy Immunol. 1994;103(4):370-7 - PubMed
- Clin Exp Immunol. 2005 Nov;142(2):242-50 - PubMed
- Pediatr Allergy Immunol. 2005 Feb;16(1):76-81 - PubMed
- Ann Allergy. 1972 Jul;30(7):407-12 - PubMed
- Nat Immunol. 2005 Oct;6(10):1047-53 - PubMed
- Thorax. 2000 Nov;55(11):925-9 - PubMed
- J Pharm Pharmacol. 2002 Apr;54(4):453-72 - PubMed
- Int J Mol Med. 2003 Jul;12(1):17-24 - PubMed
- J Immunol. 2003 Oct 1;171(7):3863-71 - PubMed
- J Immunol. 2004 May 15;172(10):5940-7 - PubMed
- Allergy. 2004 May;59(5):469-78 - PubMed
- J Asthma. 1999;36(1):1-65 - PubMed
- Infect Immun. 2005 Jul;73(7):4381-4 - PubMed
- Ciba Found Symp. 1997;206:122-34; discussion 134-9, 157-9 - PubMed
- Lung. 1999;177(2):89-100 - PubMed
- Biochem Pharmacol. 1997 Oct 1;54(7):819-24 - PubMed
- Int Arch Allergy Immunol. 1999 Jan;118(1):23-9 - PubMed
Publication Types